ROCKLATAN Trademark

Trademark Overview

On Wednesday, February 24, 2016, a trademark application was filed for ROCKLATAN with the United States Patent and Trademark Office. The USPTO has given the ROCKLATAN trademark a serial number of 86918084. The federal status of this trademark filing is REGISTERED as of Tuesday, April 2, 2019. This trademark is owned by Aerie Pharmaceuticals, Inc.. The ROCKLATAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of glaucoma and ocular hypertension
rocklatan

General Information

Serial Number86918084
Word MarkROCKLATAN
Filing DateWednesday, February 24, 2016
Status700 - REGISTERED
Status DateTuesday, April 2, 2019
Registration Number5715857
Registration DateTuesday, April 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of glaucoma and ocular hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 29, 2016
Primary Code005
First Use Anywhere DateWednesday, January 16, 2019
First Use In Commerce DateWednesday, January 16, 2019

Trademark Owner History

Party NameALCON INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressFribourg CH-1701
CH
Party NameAerie Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameAerie Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921

Trademark Events

Event DateEvent Description
Monday, February 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 27, 2016NEW APPLICATION ENTERED
Wednesday, June 8, 2016ASSIGNED TO EXAMINER
Friday, June 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 29, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 19, 2016PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 13, 2017SOU EXTENSION 1 FILED
Wednesday, March 29, 2017TEAS PETITION TO REVIVE RECEIVED
Wednesday, March 29, 2017PETITION TO REVIVE-GRANTED
Wednesday, March 29, 2017SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, March 29, 2017NOTICE OF REVIVAL - E-MAILED
Tuesday, April 11, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 26, 2017SOU EXTENSION 1 GRANTED
Thursday, April 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 12, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, September 12, 2017SOU EXTENSION 2 FILED
Tuesday, September 12, 2017SOU EXTENSION 2 GRANTED
Thursday, September 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 2, 2018SOU TEAS EXTENSION RECEIVED
Friday, March 2, 2018SOU EXTENSION 3 FILED
Friday, March 2, 2018SOU EXTENSION 3 GRANTED
Tuesday, March 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 12, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, September 12, 2018SOU EXTENSION 4 FILED
Wednesday, September 12, 2018SOU EXTENSION 4 GRANTED
Friday, September 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 28, 2019TEAS STATEMENT OF USE RECEIVED
Monday, January 28, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 28, 2019USE AMENDMENT FILED
Tuesday, January 29, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 29, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, January 30, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 27, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 28, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 2, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, March 22, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, February 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

rocklatan ocular hypertension glaucoma treatment preparations pharmaceutical